Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17021.85 236.20 NIFTY 5052.45 63.45
 

GlaxoSmithKline Pharmaceuticals Key Financial Ratios, GlaxoSmithKline Pharmaceuticals Financial Statement & Accounts

GlaxoSmithKline Pharmaceuticals

BSE: 500660  |  NSE: GLAXO  |  ISIN: INE159A01016  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Key Financial Ratios of GlaxoSmithKline Pharmaceuticals

------------------- in Rs. Cr. -------------------
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
Investment Valuation Ratios
Face Value 10.00 10.00 10.00 10.00 10.00
Dividend Per Share 24.00 28.00 31.00 36.00 40.00
Operating Profit Per Share (Rs) 46.36 51.92 58.59 66.58 71.83
Net Operating Profit Per Share (Rs) 156.63 174.03 182.04 186.37 197.91
Free Reserves Per Share (Rs) 95.66 101.49 130.54 150.16 171.44
Bonus in Equity Capital 46.59 48.03 48.03 48.03 48.03
Profitability Ratios
Operating Profit Margin(%) 29.59 29.83 32.18 35.72 36.29
Profit Before Interest And Tax Margin(%) 27.45 27.72 29.62 33.12 33.24
Gross Profit Margin(%) 31.61 32.25 35.48 38.62 35.32
Cash Profit Margin(%) 24.84 33.85 34.61 33.48 27.01
Adjusted Cash Margin(%) 20.77 20.98 23.46 25.79 27.01
Net Profit Margin(%) 23.61 32.83 33.63 32.50 32.36
Adjusted Net Profit Margin(%) 19.53 19.96 22.48 24.81 32.36
Return On Capital Employed(%) 46.37 50.26 46.67 45.60 45.06
Return On Net Worth(%) 36.04 52.93 45.66 39.51 37.41
Adjusted Return on Net Worth(%) 29.82 32.17 30.52 30.16 30.16
Return on Assets Excluding Revaluations 23.58 33.19 30.70 26.70 25.27
Return on Assets Including Revaluations 23.58 33.19 30.70 26.70 25.27
Return on Long Term Funds(%) 46.37 50.26 46.67 45.60 45.06
Liquidity And Solvency Ratios
Current Ratio 1.12 0.90 0.94 0.91 1.94
Quick Ratio 0.53 0.44 0.46 0.54 1.58
Debt Equity Ratio -- 0.01 -- -- --
Long Term Debt Equity Ratio -- 0.01 -- -- --
Debt Coverage Ratios
Interest Cover 229.20 287.00 880.22 978.15 1,326.05
Total Debt to Owners Fund 0.00 0.01 0.00 0.00 0.00
Financial Charges Coverage Ratio 175.86 209.86 426.97 472.16 1,357.13
Financial Charges Coverage Ratio Post Tax 138.66 220.55 417.04 409.93 1,129.05
Management Efficiency Ratios
Inventory Turnover Ratio 6.23 7.01 6.73 8.03 7.85
Debtors Turnover Ratio 19.11 20.55 24.12 32.15 35.03
Investments Turnover Ratio 6.62 7.32 7.09 8.51 7.85
Fixed Assets Turnover Ratio 17.48 19.13 17.70 16.85 5.94
Total Assets Turnover Ratio 1.50 1.57 1.28 1.16 1.08
Asset Turnover Ratio 5.81 6.25 6.08 5.92 5.94
Average Raw Material Holding 82.07 71.87 74.12 66.56 87.21
Average Finished Goods Held 60.63 56.13 59.67 50.01 45.50
Number of Days In Working Capital 15.74 -13.81 -7.85 -13.58 149.15
Profit & Loss Account Ratios
Material Cost Composition 43.64 43.23 42.23 39.04 38.96
Imported Composition of Raw Materials Consumed 34.04 26.17 27.94 27.41 29.86
Selling Distribution Cost Composition 7.09 6.93 6.70 6.24 5.64
Expenses as Composition of Total Sales 2.85 3.12 3.84 5.30 5.74
Cash Flow Indicator Ratios
Dividend Payout Ratio Net Profit 71.13 53.86 54.88 66.35 68.75
Dividend Payout Ratio Cash Profit 67.59 52.22 53.33 64.41 66.85
Earning Retention Ratio 14.03 11.41 17.90 13.09 14.74
Cash Earning Retention Ratio 19.16 15.75 21.32 16.38 17.64
AdjustedCash Flow Times 0.01 0.02 0.01 0.01 0.01
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
Earnings Per Share 38.15 59.28 64.40 63.48 68.07
Book Value 105.84 111.99 141.05 160.67 181.94
Source : Religare Technova
Explore GlaxoSmithKline connections